Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹411 Cr
up ₹23.2 Cr vs Mar 2018
- Stocks held
- 27
- unchanged
- Top 10 weight
- 63.9%
- of the portfolio in its ten largest
- Cash & debt
- 2.4%
- cash, money market and debt
- Moves this month
- 1 in · 1 out
- added to 10, trimmed 6
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In April 2018 it disclosed 27 stocks worth ₹411 Cr, up ₹23.2 Cr from Mar 2018. Its largest positions were Alkem Laboratories Limited (8.6%), Torrent Pharmaceuticals Limited (8.0%), Cipla Limited (7.8%); the ten largest together made up 63.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.9% of its equity. Cash and debt stood at 2.4%. Compared with Mar 2018 the fund entered 1 new stock and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
11%
Holds more stocks than 11% of peers
Cash
32%
Holds more cash than 32% of peers
What these mean: concentration · cash
Holdings in April 2018
Download CSVEvery line the fund disclosed, with the change against Mar 2018. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Alkem Laboratories Limited | 8.56% | up 1.05 pts | ₹35.2 Cr | up ₹6.1 Cr | Added |
| Torrent Pharmaceuticals Limited | 8.05% | up 0.53 pts | ₹33 Cr | up ₹3.9 Cr | Added |
| Cipla Limited | 7.83% | up 0.38 pts | ₹32.1 Cr | up ₹3.3 Cr | Added |
| Pfizer Limited | 6.72% | down 0.11 pts | ₹27.6 Cr | up ₹1.1 Cr | Added |
| IPCA Laboratories Limited | 6.34% | up 0.48 pts | ₹26 Cr | up ₹3.3 Cr | Added |
| Aurobindo Pharma Limited | 5.83% | up 0.46 pts | ₹23.9 Cr | up ₹3.1 Cr | Added |
| Sun Pharmaceutical Industries Limited | 5.77% | up 0.04 pts | ₹23.7 Cr | up ₹1.5 Cr | Added |
| Ajanta Pharma Limited | 5.24% | down 0.23 pts | ₹21.5 Cr | up ₹33 L | Added |
| Divi's Laboratories Limited | 4.80% | up 0.17 pts | ₹19.7 Cr | up ₹1.8 Cr | Added |
| Sanofi India Limited | 4.79% | down 0.63 pts | ₹19.7 Cr | down ₹1.3 Cr | Trimmed |
| Dishman Carbogen Amcis Limited | 4.29% | up 0.39 pts | ₹17.6 Cr | up ₹2.5 Cr | Added |
| Strides Pharma Science Limited | 4.11% | down 0.46 pts | ₹16.9 Cr | down ₹84 L | Trimmed |
| Piramal Enterprises Limited | 3.38% | up 0.03 pts | ₹13.9 Cr | up ₹89 L | Added |
| FDC Limited | 2.90% | down 0.19 pts | ₹11.9 Cr | down ₹5 L | Held |
| Zydus Lifesciences Limited | 2.87% | up 0.08 pts | ₹11.8 Cr | up ₹99 L | Added |
| Natco Pharma Limited | 2.47% | up 0.03 pts | ₹10.1 Cr | up ₹68 L | Added |
| Thyrocare Technologies Limited | 2.39% | up 0.13 pts | ₹9.8 Cr | up ₹1.1 Cr | Added |
| Cash, TREPS & receivables | 2.36% | up 0.63 pts | ₹9.7 Cr | up ₹3 Cr | Added |
| Max India Limited | 2.28% | down 0.08 pts | ₹9.4 Cr | up ₹22 L | Added |
| Narayana Hrudayalaya Limited | 2.23% | down 0.17 pts | ₹9.2 Cr | down ₹13 L | Trimmed |
| Dr. Lal Path Labs Limited | 1.62% | down 0.16 pts | ₹6.7 Cr | down ₹25 L | Trimmed |
| Indoco Remedies Limited | 1.58% | down 0.19 pts | ₹6.5 Cr | down ₹38 L | Trimmed |
| Sun Pharma Advanced Research Company Limited | 1.35% | up 0.07 pts | ₹5.6 Cr | up ₹59 L | Added |
| Dr. Reddy's Laboratories Limited | 1.13% | down 0.05 pts | ₹4.6 Cr | up ₹6 L | Added |
| Apollo Hospitals Enterprise Limited | 0.51% | down 0.02 pts | ₹2.1 Cr | up ₹5 L | Added |
| Shilpa Medicare Limited | 0.32% | down 0.01 pts | ₹1.3 Cr | up ₹2 L | Added |
| Unichem Laboratories Limited | 0.15% | down 0.01 pts | ₹60 L | down ₹1 L | Trimmed |
| EQ SOLARA ACTIVE PHARMA SCIENCES LTD | 0.14% | up 0.14 pts | ₹56 L | up ₹56 L | New |
What changed, Mar 2018 to Apr 2018
New New positions (1)
- EQ SOLARA ACTIVE PHARMA SCIENCES LTD0.1% · ₹56 L
Exited Exited (1)
- Lupin Limitedwas 2.3% · ₹8.8 Cr
Added Biggest additions
- Alkem Laboratories Limitedup ₹6.1 Cr (+1.05% pts)
- Torrent Pharmaceuticals Limitedup ₹3.9 Cr (+0.53% pts)
- IPCA Laboratories Limitedup ₹3.3 Cr (+0.48% pts)
- Cipla Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2018, the weight rose most in Pharmaceuticals & Biotechnology (+0.4 pts), and fell most in Healthcare Services (−0.2 pts) and Pharmaceuticals (−0.2 pts).
- Pharmaceuticals & Biotechnology76.5% → 76.9%+0.4 pts
- Healthcare Services9.5% → 9.3%−0.2 pts
- Pharmaceuticals10.6% → 10.4%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2017 | Oct 2017 | Mar 2018 | Apr 2018 |
|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.7% | 71.7% | 76.5% | 76.9% |
| Pharmaceuticals | 14.8% | 14.8% | 10.6% | 10.4% |
| Healthcare Services | 9.5% | 9.5% | 9.5% | 9.3% |
| Finance | 4.0% | 4.0% | 3.4% | 3.5% |
Allocation in Apr 2018change vs Mar 2018
- Pharmaceuticals & Biotechnology (16)76.9%▲ 0.4 pts
- Pharmaceuticals (4)10.4%▼ 0.2 pts
- Healthcare Services (5)9.3%▼ 0.2 pts
- Finance (1)3.5%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Apr 2018
2.4%
▲ 0.6 pts vs Mar 2018
- Cash alone
- 2.4%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 1.5% – 7.3%
- lowest to highest · record 7.3% in Jul 2017
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.